Skip to main content
. 2012 Aug 24;69(3):489–497. doi: 10.1007/s00228-012-1373-8

Table 2.

Summary of patients used in the evaluation

Demographic All patients Phase I study patients Phase III study patients (adult patients [ ≥ 17]) Phase III study patients (pediatric patients [2–16])
Gender (man/woman) 44/27 24/0 7/7 13/20
Age (years)a 19.6 ± 15.6 (2–86) 24.9 ± 5.1 (20–37) 38.2 ± 21.1 (17–86) 7.8 ± 4.3 (2–16)
Body weight (kg)a 43.8 ± 21.3 (7.8–74.4) 64.8 ± 5.1 (56.9–74.4) 53.5 ± 9.9 (39.0–72.2) 24.4 ± 13.0 (7.8–60.3)

aArithmetic mean ± standard deviation (minimum to maximum)